The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Flexbumin 200 g/l solution for infusion

Baxalta Innovations GmbHPA2004/002/001

Main Information

Trade NameFlexbumin 200 g/l solution for infusion
Active SubstancesHuman plasma protein
Dosage FormSolution for infusion
Licence HolderBaxalta Innovations GmbH
Licence NumberPA2004/002/001

Group Information

ATC CodeB05AA Blood substitutes and plasma protein fractions
B05AA01 albumin


License statusAuthorised
Licence Issued24/08/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceBatches marketed in Ireland shall be subject to control authority batch release in accordance with Article 114.2 of Directive 2001/83/EEC.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back